Active Pharmaceutical Ingredient

Memantine

Also known as: Namenda; Ebixa

CAS: 41100-52-1 Antidementia / NMDA Receptor Antagonist IP / BP / USP GMP Certified Aurangabad, Maharashtra, India
Memantine API — Mediocon Inc
Memantine — Pharmaceutical Grade API

Product Overview

CAS No: 41100-52-1  |  MF: C₁₂H₂₁N  |  MW: 179.31 g/mol

Memantine is a pharmaceutical-grade active ingredient classified as Antidementia / NMDA Receptor Antagonist. Mediocon Inc supplies high-purity Memantine API conforming to IP / BP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

  • NMDA receptor antagonist
  • IP/BP/USP compliant
  • Full CoA and MSDS documentation
  • GMP certified manufacturing

Applications

  • Moderate to severe Alzheimer's disease
  • Dementia management
  • Vascular dementia
  • Combined therapy with cholinesterase inhibitors

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameMemantine
Also Known AsNamenda; Ebixa
CAS Number41100-52-1
Chemical Name1-Amino-3,5-dimethyladamantane
Molecular FormulaC₁₂H₂₁N
Molecular Weight179.31 g/mol
CategoryAntidementia / NMDA Receptor Antagonist
AppearanceWhite to off-white crystalline powder
SolubilityFreely soluble in water; slightly soluble in ethanol
GradeIP / BP / USP

Analytical Specifications

ParameterSpecification
AssayNLT 99.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement
💬
Mediocon AI
Hello 👋 How can I help you today?